SG10201807059QA - Agents for influenza neutralization - Google Patents

Agents for influenza neutralization

Info

Publication number
SG10201807059QA
SG10201807059QA SG10201807059QA SG10201807059QA SG10201807059QA SG 10201807059Q A SG10201807059Q A SG 10201807059QA SG 10201807059Q A SG10201807059Q A SG 10201807059QA SG 10201807059Q A SG10201807059Q A SG 10201807059QA SG 10201807059Q A SG10201807059Q A SG 10201807059QA
Authority
SG
Singapore
Prior art keywords
agents
antibodies
influenza
neutralization
influenza neutralization
Prior art date
Application number
SG10201807059QA
Inventor
S Raguram
Viswanathan Sasisekharan
Venkataramanan Soundararajan
Ram Sasisekharan
Vidya Subramanian
Kannan Tharakaraman
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Publication of SG10201807059QA publication Critical patent/SG10201807059QA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance

Abstract

AGENTS FOR INFLUENZA NEUTRALIZATION The present invention provides antibodies (e.g., monoclonal antibodies, human antibodies, humanized antibodies, etc.), which bind to multiple influenza strains. Such antibodies are useful, for example, in the prophylaxis, treatment, diagnosis, and/or study of influenza. (No drawing to be published)
SG10201807059QA 2012-05-10 2013-03-14 Agents for influenza neutralization SG10201807059QA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261645453P 2012-05-10 2012-05-10

Publications (1)

Publication Number Publication Date
SG10201807059QA true SG10201807059QA (en) 2018-09-27

Family

ID=49548780

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201406769RA SG11201406769RA (en) 2012-05-10 2013-03-14 Agents for influenza neutralization
SG10201807059QA SG10201807059QA (en) 2012-05-10 2013-03-14 Agents for influenza neutralization

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201406769RA SG11201406769RA (en) 2012-05-10 2013-03-14 Agents for influenza neutralization

Country Status (14)

Country Link
US (4) US9683030B2 (en)
EP (2) EP2846833A4 (en)
JP (2) JP6431477B2 (en)
KR (1) KR102122618B1 (en)
CN (2) CN109265541A (en)
AU (2) AU2013260123A1 (en)
BR (1) BR112014027991A2 (en)
CA (1) CA2871160C (en)
CL (1) CL2014003052A1 (en)
HK (1) HK1207970A1 (en)
IL (1) IL235237A0 (en)
MX (1) MX2014013678A (en)
SG (2) SG11201406769RA (en)
WO (1) WO2013169377A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2871160C (en) 2012-05-10 2023-03-14 Massachusetts Institute Of Technology Agents for influenza neutralization
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
TWI702229B (en) 2014-12-19 2020-08-21 美商再生元醫藥公司 Human antibodies to influenza hemagglutinin
KR20170107562A (en) 2015-02-05 2017-09-25 얀센 백신스 앤드 프리벤션 비.브이. Binding molecules to influenza hemagglutinin aggregates and their uses
KR20180002713A (en) * 2015-05-11 2018-01-08 얀센 백신스 앤드 프리벤션 비.브이. Influenza virus neutralizing peptide mimic compound
EP3374390A1 (en) 2015-11-13 2018-09-19 Visterra, Inc. Compositions and methods for treating and preventing influenza
US20170240617A1 (en) 2016-02-24 2017-08-24 Visterra, Inc. Formulations of antibody molecules to influenza virus
KR101887876B1 (en) 2016-08-18 2018-08-13 한국과학기술연구원 Nucleic acid aptamer specifically binding to H5 subtype avian influenza virus and Diagnosis method of H5 subtype avian influenza virus using the same
US11230593B2 (en) 2019-03-25 2022-01-25 Visterra, Inc. Compositions and methods for treating and preventing influenza
IL293804A (en) 2019-12-11 2022-08-01 Visterra Inc Anti-hemagglutinin (ha) antibody molecules, compositions comprising same and uses thereof

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL23522C (en) 1927-03-23
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4957939A (en) 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4472509A (en) 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4938948A (en) 1985-10-07 1990-07-03 Cetus Corporation Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies
US4886499A (en) 1986-12-18 1989-12-12 Hoffmann-La Roche Inc. Portable injection appliance
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US5750172A (en) 1987-06-23 1998-05-12 Pharming B.V. Transgenic non human mammal milk
US5339163A (en) 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
FR2638359A1 (en) 1988-11-03 1990-05-04 Tino Dalto SYRINGE GUIDE WITH ADJUSTMENT OF DEPTH DEPTH OF NEEDLE IN SKIN
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5633076A (en) 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
EP0438803B1 (en) 1990-01-26 1997-03-12 Immunomedics, Inc. Vaccines against cancer and infectious diseases
JPH049249A (en) 1990-04-27 1992-01-14 Kusuda:Kk Facing agent spraying machine
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
JPH06247995A (en) 1991-06-24 1994-09-06 Asahi Chem Ind Co Ltd New sialyl(alpha2-6)lactotetraosylceramide
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (en) 1991-09-13 1991-09-13 Kabi Pharmacia Ab INJECTION NEEDLE ARRANGEMENT
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
JP3801196B2 (en) 1993-03-09 2006-07-26 ジェンザイム・コーポレイション Isolation of the target compound from milk
US5500161A (en) 1993-09-21 1996-03-19 Massachusetts Institute Of Technology And Virus Research Institute Method for making hydrophobic polymeric microparticles
US5827690A (en) 1993-12-20 1998-10-27 Genzyme Transgenics Corporatiion Transgenic production of antibodies in milk
WO1995024176A1 (en) 1994-03-07 1995-09-14 Bioject, Inc. Ampule filling device
US5466220A (en) 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
JP3584990B2 (en) * 1994-05-09 2004-11-04 タカラバイオ株式会社 Anti-human influenza virus antibody
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
US5893397A (en) 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
DE19643314A1 (en) 1996-10-21 1998-04-23 Boehringer Mannheim Gmbh Monoclonal antibodies against the epitope YPYDVPDYA, process for their preparation and use
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
DE19742706B4 (en) 1997-09-26 2013-07-25 Pieris Proteolab Ag lipocalin muteins
IT1298087B1 (en) 1998-01-08 1999-12-20 Fiderm S R L DEVICE FOR CHECKING THE PENETRATION DEPTH OF A NEEDLE, IN PARTICULAR APPLICABLE TO A SYRINGE FOR INJECTIONS
EP1167382A1 (en) 1999-03-31 2002-01-02 Otsuka Pharmaceutical Co., Ltd. Influenza virus hemagglutinin-binding peptides
CA2443757C (en) 2001-04-19 2016-09-27 The Scripps Research Institute In vivo incorporation of unnatural amino acids
WO2003029462A1 (en) 2001-09-27 2003-04-10 Pieris Proteolab Ag Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
AU2001298053A1 (en) 2001-09-27 2003-04-14 Pieris Proteolab Ag Muteins of apolipoprotein D
JPWO2003074570A1 (en) 2002-03-04 2005-06-30 独立行政法人科学技術振興機構 Novel branched sialo-sugar molecule and antiviral agent using the same
WO2003080672A1 (en) 2002-03-22 2003-10-02 Aprogen, Inc. Humanized antibody and process for preparing same
EP1573047B1 (en) 2002-08-20 2013-11-13 OpSaniTx LLC Lectin compositions and methods for modulating an immune response to an antigen
US20080292658A1 (en) 2004-11-11 2008-11-27 Emmie De Wit Defective Influenza Virus Particles
US7892827B2 (en) 2004-11-26 2011-02-22 Pieris Ag Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4)
WO2006069246A2 (en) 2004-12-22 2006-06-29 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7871626B2 (en) 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
WO2009002516A1 (en) * 2007-06-25 2008-12-31 The Administrators Of The Tulane Educational Fund Influenza inhibiting compositions and methods
US20090081193A1 (en) 2006-08-14 2009-03-26 Massachusetts Institute Of Technology Hemagglutinin polypeptides, and reagents and methods relating thereto
AU2007284496A1 (en) 2006-08-14 2008-02-21 Massachusetts Institute Of Technology Glycan data mining system
US20090269342A1 (en) 2006-08-14 2009-10-29 Massachusetts Institute Of Technology Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
CN101553502A (en) * 2006-08-14 2009-10-07 麻省理工学院 Hemagglutinin polypeptides, and reagents and methods relating thereto
FR2921928B1 (en) * 2007-10-08 2011-03-04 Sanofi Pasteur MONOCLONAL ANTIBODIES SPECIFIC TO INFLUENZA VIRUS HEMAGGLUTININ
AU2008338691B2 (en) * 2007-12-06 2015-01-22 Burnham Institute For Medical Research Antibodies against influenza virus and methods of use thereof
WO2009089121A2 (en) 2008-01-03 2009-07-16 Massachusetts Institute Of Technology Hemagglutinin polypeptides, and reagents and methods relating thereto
PT2257624E (en) 2008-02-05 2012-05-29 Medical Res Council Methods and compositions
RU2553325C2 (en) 2008-07-25 2015-06-10 Институт Фо Ресёч Ин Биомедицин Neutralising anti-influenza a virus antibodies and using them
US8871207B2 (en) * 2008-07-25 2014-10-28 Humabs, LLC Neutralizing anti-influenza A virus antibodies and uses thereof
EP2528615B1 (en) * 2010-01-27 2020-05-13 Massachusetts Institute of Technology Engineered polypeptide agents for targeted broad spectrum influenza neutralization
WO2011137245A2 (en) * 2010-04-30 2011-11-03 Esperance Pharmaceuticals, Inc. Lytic-peptide-her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use
BR112013007946B1 (en) 2010-10-04 2022-07-12 Massachusetts Institute Of Technology PHARMACEUTICAL AND IMMUNOGENIC COMPOSITIONS COMPRISING HEMAGGLUTININ POLYPEPTIDES
CA2871160C (en) 2012-05-10 2023-03-14 Massachusetts Institute Of Technology Agents for influenza neutralization
JP6247995B2 (en) 2014-04-22 2017-12-13 東京エレクトロン株式会社 Joining method, program, computer storage medium, joining apparatus and joining system

Also Published As

Publication number Publication date
EP3492101A2 (en) 2019-06-05
US20130302348A1 (en) 2013-11-14
US9683030B2 (en) 2017-06-20
JP6431477B2 (en) 2018-12-05
US10947300B2 (en) 2021-03-16
JP2015517492A (en) 2015-06-22
US10538578B2 (en) 2020-01-21
WO2013169377A1 (en) 2013-11-14
US20170306003A1 (en) 2017-10-26
EP2846833A1 (en) 2015-03-18
KR102122618B1 (en) 2020-06-29
CN104507500A (en) 2015-04-08
US20200123234A1 (en) 2020-04-23
HK1207970A1 (en) 2016-02-19
BR112014027991A2 (en) 2017-07-18
AU2013260123A1 (en) 2014-11-13
EP3492101A3 (en) 2019-10-23
JP2018118991A (en) 2018-08-02
US9982037B2 (en) 2018-05-29
SG11201406769RA (en) 2014-11-27
AU2018202468A1 (en) 2018-04-26
IL235237A0 (en) 2014-12-31
CN109265541A (en) 2019-01-25
CA2871160C (en) 2023-03-14
EP2846833A4 (en) 2016-01-06
US20190062407A1 (en) 2019-02-28
AU2018202468B2 (en) 2020-04-16
CL2014003052A1 (en) 2015-06-26
CA2871160A1 (en) 2013-11-14
MX2014013678A (en) 2015-02-04
KR20150008180A (en) 2015-01-21

Similar Documents

Publication Publication Date Title
SG10201807059QA (en) Agents for influenza neutralization
EA201791485A1 (en) ANTI-CD47-ANTIBODIES AND THEIR APPLICATIONS
EA032929B1 (en) Human immunodeficiency virus neutralizing antibody and methods of use thereof
EA201690167A1 (en) HUMANIZED OR CHEMICAL ANTIBODIES TO CD3
PH12015502553A1 (en) Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
MX2016003129A (en) Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1.
PH12014502132A1 (en) Anti-lgr5 antibodies and immunoconjugates
PH12014502601A1 (en) ANTI-Ly6E ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE
PH12015501059A1 (en) Anti-hemagglutinin antibodies and methods of use
CR20120577A (en) ANTIBODIES TO GDF8 HUMAN
EA201590247A1 (en) ANTIBODIES TO SIGLEC-15
MX2014009751A (en) Antibodies to integrin avvb6 and use of same to treat cancer.
EA201401077A1 (en) BISPECIFIC ANTIBODIES TO HUMAN TWEAK AND HUMAN IL17 AND THEIR APPLICATION
EA201791693A1 (en) HETERODIMERNY IMMUNOHLOBULINS
MX346206B (en) Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses.
EA201591973A1 (en) HUMAN ANTIBODIES CONNECTING WITH RSV G-PROTEIN
JO3791B1 (en) Compositions and methods for antibodies targeting bmp6
MX354988B (en) Antibody formulations and methods.
EA201491357A1 (en) ANTI-LRP5 ANTIBODIES AND METHODS OF THEIR APPLICATION
TN2015000277A1 (en) Bmp-6 antibodies
MX2015011518A (en) Met-binding agents and uses thereof.
MX2015008534A (en) ANTI- INTEGRIN ß1 ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF.
EA201400447A1 (en) ANTIBODIES TO CD1d
UA115305C2 (en) Hyr1-derived compositions and methods of treatment using same
EA201890347A1 (en) ANTIBODIES AND RESEARCH FOR DETECTION CD37